CSL Behring has awarded $87,000 in advocacy grants to four patient organizations in the United States targeted to those who have bleeding, immune and other chronic disorders.

The grants were given to:

National Hemophilia Foundation, for advocacy boot camps.

Advocacy for Patients with Chronic Illness Inc., for an online patient resource center.

Hemophilia and Bleeding Disorders of Alabama, to help enact standards of care legislation in the Alabama legislature.

Great Lakes Hemophilia Foundation, for outreach to legislators and regulators regarding access to all blood clotting factors through the Wisconsin medical programs.

The grants were awarded through the company's Local Empowerment for Advocacy Development program, which was begun in 2008. Through LEAD, CSL Behring has awarded more than $340,000 in four semiannual grant cycles. (The next deadline is April 30, 2010; information at www.cslbehring.com/leadgrants.)

CSL Behring, King of Prussia, is a subsidiary of CSL Ltd., a Melbourne, Australia, biopharma company.    - Roslyn Rudolph